Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides ...

This season’s FluLaval and Fluarix vaccines will include the 2009 H1N1 pandemic strain among the three vaccine strains. GlaxoSmithKline expects to supply more than 30 million doses combined of ...

The updated labeling includes the immunogenicity and safety data from an open-label, multicenter phase 3 trial (NCT01954251) of 828 adults aged ≥50 years who received either Fluarix Quadrivalent ...

Here is some other vaccine news of note for the week: > GlaxoSmithKline won an FDA label expansion for its Fluarix Quadrivalent. Children 6 months and older are now eligible for the flu vaccine.

While more than 126 million doses of the test vaccine, Fluarix, have been distributed in more than 70 countries worldwide, Fluarix has never been tested or licensed for use in the United States.

"The expanded indication for FLUARIX ® QUADRIVALENT in the US builds upon GSK's commitment to being a reliable supplier and partner to healthcare providers and their patients. We can now offer ...

GlaxoSmithKline has moved for FDA approval of its flu vaccine Fluarix. If approved, it would become the fourth flu vaccine approved for the US market and could help stabilize the market for the drug.

ROCKVILLE, Md. The Food and Drug Administration announced the approval of GlaxoSmithKline’s Fluarix, a seasonal flu vaccine previously approved only for adults, for use in children and teenagers ...

As a severe flu season continues to unfold in the U.S., GlaxoSmithKline is touting phase 3 study data showing its Fluarix Tetra can protect young children who are among the most vulnerable to the ...

The U.S. Food and Drug Administration has approved Fluarix Quadrivalent to immunize children age 3 and older and adults against flu virus subtypes A and B contained in the vaccine. It is the first ...

The TGA has agreed that the Fluarix vaccine can continue to be used, but it advises doctors to visually inspect the pre-filled syringes prior to administration.